CINTHIA LYVERS: Open Payments
NPI 1235585613 · LANSDOWNE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 5 payments from 4 companies in 2025. Trend: 2023 $112 · 2024 $0 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $244 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $123 |
| ABBVIE INC. | 1 | $100 |
Products named: CAPLYTA, REXULTI, Qelbree, VRAYLAR.
Industry payments across VA — which companies pay providers there.
